A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma

BACKGROUND: Gemcitabine and docetaxel have been shown to be active in pre-treated relapsed leiomyosarcoma. This study investigated the combination as first line treatment in patients with unresectable locally advanced/metastatic leiomyosarcoma. METHODS: Patients received gemcitabine 900 mg/m(2) days...

Descripción completa

Detalles Bibliográficos
Autores principales: Seddon, Beatrice, Scurr, Michelle, Jones, Robin L, Wood, Zoe, Propert-Lewis, Cerys, Fisher, Cyril, Flanagan, Adrienne, Sunkersing, Jonanthan, A’Hern, Roger, Whelan, Jeremy, Judson, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434867/
https://www.ncbi.nlm.nih.gov/pubmed/25987978
http://dx.doi.org/10.1186/s13569-015-0029-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434867/
https://www.ncbi.nlm.nih.gov/pubmed/25987978
http://dx.doi.org/10.1186/s13569-015-0029-8

Ejemplares similares